Monsanto Co. (MON) EVP Robert T. Fraley Sells 80,631 Shares of Stock
Monsanto Co. (NYSE:MON) EVP Robert T. Fraley sold 80,631 shares of Monsanto stock in a transaction on Friday, October 14th. The shares were sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the completion of the transaction, the executive vice president now owns 38,711 shares in the company, valued at $3,950,070.44. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Monsanto Co. (NYSE:MON) opened at 102.11 on Monday. The stock has a market cap of $44.69 billion, a PE ratio of 34.17 and a beta of 1.19. Monsanto Co. has a 12-month low of $83.73 and a 12-month high of $114.26. The firm has a 50-day moving average price of $104.39 and a 200-day moving average price of $101.78.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business earned ($0.19) EPS. Analysts forecast that Monsanto Co. will post $4.89 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 2.12%. The ex-dividend date is Wednesday, October 5th. Monsanto’s dividend payout ratio is currently 71.05%.
MON has been the topic of a number of analyst reports. Vetr lowered shares of Monsanto from a “strong-buy” rating to a “buy” rating and set a $116.47 price objective on the stock. in a research report on Thursday, July 14th. Credit Agricole SA restated a “buy” rating on shares of Monsanto in a research report on Saturday, July 2nd. Deutsche Bank AG restated a “buy” rating and set a $118.00 target price on shares of Monsanto in a research report on Thursday, June 30th. Jefferies Group restated a “buy” rating on shares of Monsanto in a research report on Wednesday, June 29th. Finally, Monness Crespi & Hardt upgraded shares of Monsanto from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $106.93 to $130.00 in a research report on Monday, August 8th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Monsanto currently has a consensus rating of “Buy” and a consensus target price of $114.65.
A number of large investors have recently made changes to their positions in MON. Virginia Retirement System acquired a new stake in shares of Monsanto during the first quarter valued at about $626,000. JPMorgan Chase & Co. increased its stake in shares of Monsanto by 2.3% in the first quarter. JPMorgan Chase & Co. now owns 828,673 shares of the company’s stock valued at $72,708,000 after buying an additional 18,961 shares in the last quarter. M&T Bank Corp increased its stake in shares of Monsanto by 16.4% in the first quarter. M&T Bank Corp now owns 77,720 shares of the company’s stock valued at $6,820,000 after buying an additional 10,927 shares in the last quarter. Carnick & Kubik LLC acquired a new stake in shares of Monsanto during the first quarter valued at about $130,000. Finally, Meiji Yasuda Asset Management Co Ltd. increased its stake in shares of Monsanto by 4.2% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 30,933 shares of the company’s stock valued at $2,714,000 after buying an additional 1,260 shares in the last quarter. 78.94% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.